Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 54,800 shares, a growth of 896.4% from the December 15th total of 5,500 shares. Based on an average daily volume of 573,800 shares, the short-interest ratio is currently 0.1 days.
Daiichi Sankyo Stock Performance
Shares of DSNKY stock traded up $0.19 on Monday, reaching $26.16. 387,192 shares of the company's stock traded hands, compared to its average volume of 176,070. The business's 50 day moving average price is $29.34 and its two-hundred day moving average price is $33.80. The company has a market capitalization of $49.60 billion and a P/E ratio of 0.23. Daiichi Sankyo has a 12-month low of $25.11 and a 12-month high of $42.48.
About Daiichi Sankyo
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Featured Articles
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
